Results 161 to 170 of about 6,071 (199)
Some of the next articles are maybe not open access.
Palivizumab prophylaxis in ‘late preterm’ newborns
The Journal of Maternal-Fetal & Neonatal Medicine, 2010In the last decades the preterm birth rate rose more than 20%, largely because of an increase among deliveries of 'late preterm' infants, i.e. those born at 34 to 36 weeks gestational age. Late preterm infants are more susceptible to infection by pathogens, such as respiratory syncytial virus (RSV), possibly because of the immaturity of both the ...
LANARI, MARCELLO +2 more
openaire +3 more sources
To Palivizumab or not to Palivizumab – that is the question
Paediatric Respiratory Reviews, 2013openaire +2 more sources
Controversies in Palivizumab Use
The Pediatric Infectious Disease Journal, 2004Timothy P, Stevens, Caroline B, Hall
openaire +2 more sources